Basics Vir Biotechnology, Inc. IPO Date: October 11, 2019 Sector: Healthcare Industry: Biotech Market Cap: $904.31M Activated in VL: True Average Daily Range Avg Daily Range: $0.84 | 3.13% Avg Daily Range (30 D): $0.20 | 3.48% Avg Daily Range (90 D): $0.16 | 2.86% Institutional Daily Volume Avg Daily Volume: .99M Avg Daily Volume (30 D): 1.47M Avg Daily Volume (90 D): 1.25M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 99 Institutional Trades Total Inst.Trades: 3,046 Avg Inst. Trade: $2.46M Avg Inst. Trade (30 D): $1M Avg Inst. Trade (90 D): $.91M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.51M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $.92M Avg Closing Volume: 179.99K     News Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights Aug 7, 2025 @ 4:32 AM Vir (VIR) Q2 Revenue Drops 61% Source: Jesterai Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research May 24, 2024 @ 5:01 PM Evaluating Vir Biotechnology: Insights From 5 Fina... Source: Benzinga Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.17 $-.8 Diluted EPS $-1.17 $-.8 Revenue $ $ .24M $ 1.21M Gross Profit $ $ $ 1.2M Net Income / Loss $ $ -163.14M $ -110.96M Operating Income / Loss $ $ -173.44M $ -118.42M Cost of Revenue $ $ $ .01M Net Cash Flow $ $ -127.02M $ -61.72M PE Ratio